Grifols, S.A. Logo

Grifols, S.A.

GRF.MC

(1.2)
Stock Price

11,13 EUR

1.55% ROA

3.25% ROE

35.98x PER

Market Cap.

6.340.668.445,00 EUR

171.91% DER

0% Yield

2.78% NPM

Grifols, S.A. Stock Analysis

Grifols, S.A. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Grifols, S.A. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE falls within an average range (3.41%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

2 ROA

The stock's ROA (1.8%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

3 PBV

The stock's PBV ratio (1.4x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

4 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

5 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (310), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

6 DER

The company has a high debt to equity ratio (159%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

7 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

9 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

10 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

11 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

Grifols, S.A. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Grifols, S.A. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Grifols, S.A. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Grifols, S.A. Revenue
Year Revenue Growth
2005 524.277.000
2006 648.797.000 19.19%
2007 703.291.000 7.75%
2008 814.311.000 13.63%
2009 913.186.000 10.83%
2010 990.730.000 7.83%
2011 1.795.613.000 44.82%
2012 2.620.944.000 31.49%
2013 2.741.732.000 4.41%
2014 3.355.384.000 18.29%
2015 3.934.563.000 14.72%
2016 4.049.830.000 2.85%
2017 4.318.073.000 6.21%
2018 4.486.724.000 3.76%
2019 5.098.691.000 12%
2020 5.340.038.000 4.52%
2021 4.933.118.000 -8.25%
2022 6.063.967.000 18.65%
2023 6.389.928.000 5.1%
2023 6.591.977.000 3.07%
2024 7.271.628.000 9.35%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Grifols, S.A. Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 124.443.000 100%
2013 123.271.000 -0.95%
2014 180.753.000 31.8%
2015 224.193.000 19.38%
2016 197.617.000 -13.45%
2017 288.320.000 31.46%
2018 240.661.000 -19.8%
2019 276.018.000 12.81%
2020 294.216.000 6.19%
2021 354.881.000 17.09%
2022 361.140.000 1.73%
2023 353.792.000 -2.08%
2023 330.551.000 -7.03%
2024 274.716.000 -20.32%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Grifols, S.A. General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 265.040.000
2006 313.156.000 15.36%
2007 300.037.000 -4.37%
2008 350.198.000 14.32%
2009 405.084.000 13.55%
2010 436.428.000 7.18%
2011 877.669.000 50.27%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 436.672.000 100%
2022 523.299.000 16.55%
2023 0 0%
2023 1.259.534.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Grifols, S.A. EBITDA
Year EBITDA Growth
2005 64.590.000
2006 87.693.000 26.35%
2007 190.713.000 54.02%
2008 243.673.000 21.73%
2009 257.022.000 5.19%
2010 241.288.000 -6.52%
2011 373.169.000 35.34%
2012 789.480.000 52.73%
2013 843.653.000 6.42%
2014 1.028.106.000 17.94%
2015 1.141.963.000 9.97%
2016 1.142.119.000 0.01%
2017 1.194.813.000 4.41%
2018 1.206.579.000 0.98%
2019 1.489.895.000 19.02%
2020 1.359.134.000 -9.62%
2021 955.389.000 -42.26%
2022 1.112.026.000 14.09%
2023 1.002.092.000 -10.97%
2023 1.179.834.000 15.07%
2024 1.458.060.000 19.08%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Grifols, S.A. Gross Profit
Year Gross Profit Growth
2005 370.380.000
2006 445.625.000 16.89%
2007 523.865.000 14.94%
2008 638.631.000 17.97%
2009 741.147.000 13.83%
2010 763.133.000 2.88%
2011 1.328.911.000 42.57%
2012 1.329.599.000 0.05%
2013 1.417.852.000 6.22%
2014 1.699.214.000 16.56%
2015 1.930.998.000 12%
2016 1.912.291.000 -0.98%
2017 2.152.011.000 11.14%
2018 2.049.560.000 -5%
2019 2.341.232.000 12.46%
2020 2.255.165.000 -3.82%
2021 1.962.596.000 -14.91%
2022 2.231.530.000 12.05%
2023 2.527.332.000 11.7%
2023 2.322.701.000 -8.81%
2024 2.483.104.000 6.46%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Grifols, S.A. Net Profit
Year Net Profit Growth
2005 25.556.000
2006 45.394.000 43.7%
2007 87.774.000 48.28%
2008 121.728.000 27.89%
2009 147.972.000 17.74%
2010 115.513.000 -28.1%
2011 50.307.000 -129.62%
2012 256.686.000 80.4%
2013 345.551.000 25.72%
2014 470.253.000 26.52%
2015 532.145.000 11.63%
2016 545.456.000 2.44%
2017 662.700.000 17.69%
2018 596.642.000 -11.07%
2019 625.146.000 4.56%
2020 618.546.000 -1.07%
2021 265.327.000 -133.13%
2022 208.279.000 -27.39%
2023 238.172.000 12.55%
2023 59.315.000 -301.54%
2024 59.364.000 0.08%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Grifols, S.A. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 1 0%
2014 1 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%
2020 1 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Grifols, S.A. Free Cashflow
Year Free Cashflow Growth
2005 119.724.000
2006 49.076.000 -143.96%
2007 88.644.000 44.64%
2008 73.409.000 -20.75%
2009 -30.590.000 339.98%
2010 850.000 3698.82%
2011 60.329.000 98.59%
2012 340.990.000 82.31%
2013 419.162.000 18.65%
2014 691.889.000 39.42%
2015 175.758.000 -293.66%
2016 260.588.000 32.55%
2017 518.773.000 49.77%
2018 429.706.000 -20.73%
2019 156.628.000 -174.35%
2020 747.776.000 79.05%
2021 88.807.000 -742.02%
2021 281.887.000 68.5%
2022 -386.427.000 172.95%
2023 53.277.000 825.32%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Grifols, S.A. Operating Cashflow
Year Operating Cashflow Growth
2005 119.724.000
2006 49.076.000 -143.96%
2007 88.644.000 44.64%
2008 73.409.000 -20.75%
2009 88.180.000 16.75%
2010 104.252.000 15.42%
2011 220.228.000 52.66%
2012 507.118.000 56.57%
2013 592.011.000 14.34%
2014 978.928.000 39.52%
2015 742.778.000 -31.79%
2016 553.278.000 -34.25%
2017 841.746.000 34.27%
2018 737.428.000 -14.15%
2019 568.933.000 -29.62%
2020 1.110.336.000 48.76%
2021 161.633.000 -586.95%
2021 596.975.000 72.92%
2022 -10.867.000 5593.47%
2023 156.386.000 106.95%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Grifols, S.A. Capital Expenditure
Year Capital Expenditure Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 118.770.000 100%
2010 103.402.000 -14.86%
2011 159.899.000 35.33%
2012 166.128.000 3.75%
2013 172.849.000 3.89%
2014 287.039.000 39.78%
2015 567.020.000 49.38%
2016 292.690.000 -93.73%
2017 322.973.000 9.38%
2018 307.722.000 -4.96%
2019 412.305.000 25.37%
2020 362.560.000 -13.72%
2021 72.826.000 -397.84%
2021 315.088.000 76.89%
2022 375.560.000 16.1%
2023 103.109.000 -264.24%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Grifols, S.A. Equity
Year Equity Growth
2005 55.947.000
2006 368.352.000 84.81%
2007 384.166.000 4.12%
2008 481.279.000 20.18%
2009 578.528.000 16.81%
2010 707.390.000 18.22%
2011 1.664.994.000 57.51%
2012 1.880.741.000 11.47%
2013 2.107.204.000 10.75%
2014 2.662.888.000 20.87%
2015 3.301.390.000 19.34%
2016 3.727.978.000 11.44%
2017 3.633.965.000 -2.59%
2018 4.696.604.000 22.63%
2019 6.845.768.000 31.39%
2020 6.720.055.000 -1.87%
2021 8.147.035.000 17.52%
2022 8.457.544.000 3.67%
2023 8.568.690.000 1.3%
2023 7.972.485.000 -7.48%
2024 8.295.274.000 3.89%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Grifols, S.A. Assets
Year Assets Growth
2005 821.683.000
2006 913.674.000 10.07%
2007 939.569.000 2.76%
2008 1.180.239.000 20.39%
2009 1.657.177.000 28.78%
2010 1.888.982.000 12.27%
2011 5.807.718.000 67.47%
2012 5.627.474.000 -3.2%
2013 5.841.036.000 3.66%
2014 8.449.749.000 30.87%
2015 9.601.715.000 12%
2016 10.129.772.000 5.21%
2017 10.920.264.000 7.24%
2018 12.477.046.000 12.48%
2019 15.542.611.000 19.72%
2020 15.274.776.000 -1.75%
2021 19.233.835.000 20.58%
2022 21.533.977.000 10.68%
2023 22.064.498.000 2.4%
2023 21.454.670.000 -2.84%
2024 22.291.454.000 3.75%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Grifols, S.A. Liabilities
Year Liabilities Growth
2005 765.736.000
2006 545.322.000 -40.42%
2007 555.403.000 1.82%
2008 698.960.000 20.54%
2009 1.078.649.000 35.2%
2010 1.181.592.000 8.71%
2011 4.142.724.000 71.48%
2012 3.746.733.000 -10.57%
2013 3.733.832.000 -0.35%
2014 5.786.861.000 35.48%
2015 6.300.325.000 8.15%
2016 6.401.794.000 1.59%
2017 7.286.299.000 12.14%
2018 7.780.442.000 6.35%
2019 8.696.843.000 10.54%
2020 8.554.721.000 -1.66%
2021 11.086.800.000 22.84%
2022 13.076.433.000 15.22%
2023 13.495.808.000 3.11%
2023 13.468.378.000 -0.2%
2024 13.982.305.000 3.68%

Grifols, S.A. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
10.08
Net Income per Share
0.28
Price to Earning Ratio
35.98x
Price To Sales Ratio
0.93x
POCF Ratio
21.96
PFCF Ratio
44.44
Price to Book Ratio
1.22
EV to Sales
2.17
EV Over EBITDA
12.39
EV to Operating CashFlow
47.65
EV to FreeCashFlow
104.2
Earnings Yield
0.03
FreeCashFlow Yield
0.02
Market Cap
6,34 Bil.
Enterprise Value
14,87 Bil.
Graham Number
7.2
Graham NetNet
-13.58

Income Statement Metrics

Net Income per Share
0.28
Income Quality
2.7
ROE
0.03
Return On Assets
0.01
Return On Capital Employed
0.05
Net Income per EBT
0.61
EBT Per Ebit
0.32
Ebit per Revenue
0.14
Effective Tax Rate
0.29

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.05
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.37
Operating Profit Margin
0.14
Pretax Profit Margin
0.05
Net Profit Margin
0.03

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.46
Free CashFlow per Share
0.21
Capex to Operating CashFlow
0.54
Capex to Revenue
0.02
Capex to Depreciation
0.79
Return on Invested Capital
0.05
Return on Tangible Assets
0.02
Days Sales Outstanding
49.83
Days Payables Outstanding
74.75
Days of Inventory on Hand
308.57
Receivables Turnover
7.32
Payables Turnover
4.88
Inventory Turnover
1.18
Capex per Share
0.25

Balance Sheet

Cash per Share
3,30
Book Value per Share
12,23
Tangible Book Value per Share
-2.46
Shareholders Equity per Share
8.23
Interest Debt per Share
15.01
Debt to Equity
1.72
Debt to Assets
0.43
Net Debt to EBITDA
7.11
Current Ratio
1.68
Tangible Asset Value
-1,67 Bil.
Net Current Asset Value
-7,07 Bil.
Invested Capital
17000424000
Working Capital
2,80 Bil.
Intangibles to Total Assets
0.45
Average Receivables
0,87 Bil.
Average Payables
0,85 Bil.
Average Inventory
3541281500
Debt to Market Cap
1.52

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Grifols, S.A. Dividends
Year Dividends Growth
2007 0
2008 0 0%
2009 1 0%
2010 0 0%
2013 0 0%
2014 0 0%
2015 1 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%

Grifols, S.A. Profile

About Grifols, S.A.

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuum–from prevention, screening, diagnosis, and prognosis to disease and treatment monitoring–to serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.

CEO
Mr. Jose Ignacio Abia Buenach
Employee
23.505
Address
Avinguda de la Generalitat, 152
Barcelona, 08174

Grifols, S.A. Executives & BODs

Grifols, S.A. Executives & BODs
# Name Age
1 Mr. Sergio Roura Adell
President of Commercial Tech Support
70
2 Mr. Thomas H. Glanzmann
Executive Chairman
70
3 Mr. Jose Ignacio Abia Buenache
Chief Executive Officer & Director
70
4 Mr. Alfredo Arroyo Guerra
Chief Financial Officer & Vice President
70
5 Mr. Lluis Pons Gomez
Senior Vice President of Strategy & Chief Operating Officer Office
70
6 Ms. Nuria Pascual Lapeña
Vice President of Corporate Treasury, Risk Management Investor Relation & Sustainability Officer
70
7 Mr. David Ian Bell
Chief Corporate Development, Legal & Data Protection Officer
70
8 Ms. Maria Teresa-Rioné Llano
Chief Communications Officer
70
9 Mr. Camille Alpi
Chief Human Resources & Talent Officer
70
10 Mr. Vicente Blanquer Torre
Chief Quality Officer
70

Grifols, S.A. Competitors